secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2024-08-23T23:59:59+00:00
Accession:  0001493152-24-033756
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio raises $6M via Series C Preferred; director Suren Ajjarapu resigns
------------------------------------------------------------------------------

- Sold 600 shares of Series C Preferred at $10,000 each for $6.0M aggregate to The Patel Family, LLP.
- Series C carries 7.5% annual cumulative dividend, convertible after 6 months at VWAP floor $0.6172.
- Conversion subject to 9.99% beneficial ownership limitation; pre-funded warrants issued if exceeded.
- Director Suren Ajjarapu resigned effective August 21, 2024, with no disagreement with the company.
- Proceeds from unregistered sale used for general corporate purposes; stock not registered under Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224033756/0001493152-24-033756-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224033756/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-033756

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer